Skip to content

Hutchmed (China)

US · HCM #2639 by market cap Listed 2016
13.22 -0.23 -1.71%
Periodic snapshot; not a real-time feed. · 2026-11-20 16:10

Quant vs Street three independent views, side by side

StockVane factor grade
A-
Momentum strategy signal
Sell
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 2 analysts

Buy
Avg price target 18.25 +38.0%
Price target rangecurrent 13.22
Low18.00
Avg18.25
High18.50
Buy 100% Hold 0% Sell 0%
Recent ratings (19)
DateFirmAnalystRatingTarget
2026-10-27 BofA Securities -- Buy 18.00
2026-10-26 BofA Securities -- Buy 18.00
2026-10-19 BofA Securities -- Buy 18.00
2026-09-21 BofA Securities -- Buy 18.00
2026-09-03 Daiwa -- Buy 18.50
2026-07-31 BofA Securities -- Buy 16.00
2026-07-23 Goldman Sachs -- Hold 14.00
2026-07-07 BofA Securities -- Buy 17.00
2026-05-31 BofA Securities -- Buy 20.00
2026-05-28 Morgan Stanley -- Hold 13.60
2026-05-21 BofA Securities -- Buy 20.00
2026-03-09 BofA Securities -- Buy 20.00
2026-03-06 BofA Securities -- Buy 21.00
2026-01-22 BofA Securities -- Buy 22.00
2026-01-07 BofA Securities -- Buy 22.00
2026-01-06 BofA Securities -- Buy 22.00
2025-12-09 BofA Securities -- Buy 25.00
2025-10-22 BofA Securities -- Buy 25.00
2025-10-14 BofA Securities -- Buy 25.00

Price target trend monthly average, last 3 years

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q2 2026-07-30 -- ±33.79% -5.44% (in line)
2025/Q4 2026-03-05 -- -- +1.50%
2025/Q2 2025-08-07 -- ±14.76% -9.01% (in line)
2024/Q4 2025-03-19 -- ±11.04% +8.23% (in line)
2024/Q2 2024-07-31 -- ±23.72% +8.00% (in line)
2023/Q4 2024-02-28 -- -- -4.88%
2023/Q2 2023-07-31 -- ±20.99% -4.42% (in line)
2022/Q4 2023-02-28 -- ±18.78% +5.35% (in line)
2022/Q2 2022-08-01 -- ±27.85% -7.65% (in line)
2021/Q4 2022-03-03 -- ±16.61% -6.95% (in line)
2021/Q2 2021-07-28 -- ±19.71% +14.71% (in line)
2020/Q4 2021-03-04 -- -- -7.16%

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 16:10:04 · For reference only, not investment advice and not tailored to your situation.

Hutchmed (China) discussion 0 comments

Add a comment